Sarepta Therapeutics (SRPT) Soars: Stock Rises 12.8% - Tale of the Tape

Comment

Shutterstock photo

Sarepta Therapeutics, Inc. ( SRPT ) was a big mover last session, as its shares rose nearly 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent downtrend for the company, as the stock is now down over 24% in the past one-month timeframe.

In the last 30 days, the company witnessed one negative estimate revision and the Zacks Consensus Estimate also moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday's move higher lasts.

Sarepta Therapeutics currently has a Zacks Rank #4 (Sell) while its Earnings ESP is positive.

Other better-ranked stocks in the medical sector include Actelion Ltd. ( ALIOF ), Illumina Inc. ( ILMN ) and Curis, Inc. ( CRIS ). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

SAREPTA THERAP (SRPT): Free Stock Analysis Report

ACTELION LTD (ALIOF): Get Free Report

CURIS INC (CRIS): Free Stock Analysis Report

ILLUMINA INC (ILMN): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: Investing , Investing Ideas , Stocks
More Headlines for: SRPT , ALIOF , CRIS , ILMN


More from Zacks.com

Subscribe






Zacks.com
Contributor:

Zacks.com

Equity Research
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com